首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   65篇
  免费   8篇
  73篇
  2021年   1篇
  2019年   1篇
  2017年   1篇
  2016年   4篇
  2015年   6篇
  2014年   4篇
  2011年   3篇
  2010年   4篇
  2009年   4篇
  2008年   2篇
  2007年   3篇
  2006年   3篇
  2005年   4篇
  2004年   4篇
  2003年   3篇
  2001年   1篇
  2000年   3篇
  1998年   5篇
  1997年   1篇
  1996年   1篇
  1995年   2篇
  1994年   1篇
  1990年   1篇
  1989年   1篇
  1988年   2篇
  1981年   2篇
  1979年   1篇
  1977年   2篇
  1976年   1篇
  1968年   1篇
  1966年   1篇
排序方式: 共有73条查询结果,搜索用时 0 毫秒
71.
Autologous disc cell implantation, growth factors and gene therapy appear to be promising therapies for disc regeneration. Unfortunately, the replicative lifespan and growth kinetics of human nucleus pulposus (NP) cells related to host age are unclear. We investigated the potential relations among age, replicative lifespan and growth rate of NP cells, and determined the age range that is suitable for cell-based biological therapies for degenerative disc diseases. We used NP tissues classified by decade into five age groups: 30s, 40s, 50s, 60s and 70s. The mean cumulative population doubling level (PDL) and population doubling rate (PDR) of NP cells were assessed by decade. We also investigated correlations between cumulative PDL and age, and between PDR and age. The mean cumulative PDL and PDR decreased significantly in patients in their 60s. The mean cumulative PDL and PDR in the younger groups (30s, 40s and 50s) were significantly higher than those in the older groups (60s and 70s). There also were significant negative correlations between cumulative PDL and age, and between PDR and age. We found that the replicative lifespan and growth rate of human NP cells decreased with age. The replicative potential of NP cells decreased significantly in patients 60 years old and older. Young individuals less than 60 years old may be suitable candidates for NP cell-based biological therapies for treating degenerative disc diseases.  相似文献   
72.

Background  

In research laboratories using DNA-microarrays, usually a number of researchers perform experiments, each generating possible sources of error. There is a need for a quick and robust method to assess data quality and sources of errors in DNA-microarray experiments. To this end, a novel and cost-effective validation scheme was devised, implemented, and employed.  相似文献   
73.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号